Zhu et al. have demonstrated that IGF-1 enhances the expression of VEGF-C via the PI3K/Akt and MAPK/ERK1/2 signaling pathways in MDA-MB-231 breast cancer cells. This evidence concerns the gene MAPK3 and breast carcinoma.